Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dickmann

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|March 27, 2004
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9Leslie J Dickmann, Charles W Locuson, Jeffrey P Jones, et al.
Clinical and Translational Science|November 16, 2019
Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer TherapyEric Reyner, Bert Lum, Jing Jing, et al.
Addictive Behaviors|April 29, 2009
Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive usePatricia J Dickmann, Marc E Mooney, Sharon S Allen, et al.
Biochemical Pharmacology|May 8, 2004
Differential activation of CYP2C9 variants by dapsoneMatthew A Hummel, Leslie J Dickmann, Allan E Rettie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 11, 2011
Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte cultureLeslie J Dickmann, Sonal K Patel, Dan A Rock, et al.
Brain Stimulation|November 28, 2017
Transcranial Direct Current Stimulation (tDCS) paired with a decision-making task reduces risk-taking in a clinically impulsive sampleCasey S Gilmore, Patricia J Dickmann, Brent G Nelson, et al.
Journal of Clinical Pharmacology|July 17, 2001
Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probeJ S Kim, A N Nafziger, A Gaedigk, et al.
Biochemical Pharmacology|March 20, 2012
Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppressionLeslie J Dickmann, Helen J McBride, Sonal K Patel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2008
Re-engineering of CYP2C9 to probe acid-base substrate selectivityGuoying Tai, Leslie J Dickmann, Nicholas Matovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2016
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Robert S Foti, Nina Isoherranen, Alex Zelter, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|March 27, 2004
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9Leslie J Dickmann, Charles W Locuson, Jeffrey P Jones, et al.
Clinical and Translational Science|November 16, 2019
Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer TherapyEric Reyner, Bert Lum, Jing Jing, et al.
Addictive Behaviors|April 29, 2009
Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive usePatricia J Dickmann, Marc E Mooney, Sharon S Allen, et al.
Biochemical Pharmacology|May 8, 2004
Differential activation of CYP2C9 variants by dapsoneMatthew A Hummel, Leslie J Dickmann, Allan E Rettie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 11, 2011
Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte cultureLeslie J Dickmann, Sonal K Patel, Dan A Rock, et al.
Brain Stimulation|November 28, 2017
Transcranial Direct Current Stimulation (tDCS) paired with a decision-making task reduces risk-taking in a clinically impulsive sampleCasey S Gilmore, Patricia J Dickmann, Brent G Nelson, et al.
Journal of Clinical Pharmacology|July 17, 2001
Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probeJ S Kim, A N Nafziger, A Gaedigk, et al.
Biochemical Pharmacology|March 20, 2012
Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppressionLeslie J Dickmann, Helen J McBride, Sonal K Patel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2008
Re-engineering of CYP2C9 to probe acid-base substrate selectivityGuoying Tai, Leslie J Dickmann, Nicholas Matovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2016
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Robert S Foti, Nina Isoherranen, Alex Zelter, et al.
Pageof 4